ERBB2 and breast carcinoma: Gene expression studies have identified at least five intrinsic subtypes of breast cancer, and the most common clinical markers of breast cancer heterogeneity to date have been presence or absence of estrogen receptors (ERs) or progesterone receptors (PRs) and overexpression of human epidermal growth factor receptor 2 (HER2) [14].